Bing

SEARCH HISTORY

The online stock research program MarketSmith is his bedrock ... Related: See the economy recovery in 17 charts Some of the stocks he likes now include: Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Actavis (ACT), and United Rentals (URI).
CNN Money · 6/8/2014
Chart courtesy of www.StockCharts.com The stock has performed extremely well over the past year, and I would prefer waiting for a pullback before looking to add this type of company into a well-diversified portfolio. For the health of your investment ...
Trefis · 2/4/2014
Results of the tests are used to help develop new treatments as well as to analyze tumors that can be targeted by drugs. Shares are trading on the Nasdaq under the stock symbol ILMN for $214.45 per share.
San Diego Business Journal · 7/22/2015
Illumina Inc. (ILMN:NASDAQ), for example, was able to take the cost of ... It's going to be there anyway, so try to make volatility your friend." I think the stock and biotech index charts showing the multiyear biotech …
investorideas.com · 8/13/2015
Volatility
ILMN closed Tuesday's trading at $237.54, down $2.48 or 1.03%, on the Nasdaq. The stock further dropped $21.04 or 8.86% in after-hours trade. Copyright RTT News/dpa-AFX
Finanznachrichten · 7/22/2015
Illumina /quotes/zigman/83650/delayed /quotes/nls/ilmn ILMN shares were up $11.13 to $136.16 in recent ... his price target on shares to $140 from $110. “While [Illumina's] stock is expensive, in our view, by any measure, we believe investors will ...
Market Watch Commentary · ByRuss Britt · 1/18/2014
Illumina (ILMN) launched its initial public offering in July 2000. This wasn't the best time to debut. A bear market was under way. The San Diego-based maker of genetic analysis tools beat the odds for a while. By late September 2000, the stock hit 51.63 ...
Investor's Business Daily · ByPaul Whitfield · 8/19/2015
is 33 and that of Illumina (ILMN) is 58. By contrast, the long-term average P/E of the S&P 500 is 15.5. Yes, many biotech and pharmaceutical companies will see sharply rising earnings in the coming years. But their stock prices already reflect a whole lot ...
Kiplinger · 6/2/2015
Illumina (ILMN) is trading down on a volume of 5.2 million, or 1.5 times its standard daily volume. Trading at $50.64, the stock is down 3.7%. The stock is trading 15.6% above its 200-day moving average. Trading at a volume of 842,102, or 4.8 times its ...
Fox Business · 4/12/2012
Overall, Illumina's stock price increased 10 of the last 16 earnings announcements, with an average gain of 8.72% in the days circling the news. The one time the company missed in 2009, ILMN's price got hammered by 23%, ouch. For those keeping mental …
istock Analyst · 10/19/2012